Pediatric Nanomedicine Distinguished Lecture Series

*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************

Event Details
  • Date/Time:
    • Tuesday August 28, 2012
      12:15 pm - 1:15 pm
  • Location: Emory Conference Center Hotel, Starvine II Meeting Rm.
  • Phone:
  • URL: http://emoryconferencecenter.com/
  • Email:
  • Fee(s):
    N/A
  • Extras:
Contact

Amy Tang

Summaries

Summary Sentence: "Nanomedicine and Stem Cell Research Programs at NHLBI" - Denis Buxton, PhD - NHLBI

Full Summary: Pediatric Nanomedicine Distinguished Lecture Series - "NHLBI Support for Novel Diagnostics & Therapeutics: Pediatrics & Beyond" - Denis Buxton, PhD - NHLBI

"NHLBI Support for Novel Diagnostics & Therapeutics: Pediatrics & Beyond"

Denis Buxton, PhD
Director, Program in Basic & Early Translational Research Division of Cardiovascular Sciences
National Heart, Lung, and Blood Institute

NHLBI supports a broad range of programs focused on the development of novel diagnostics and therapeutics. Some are focused specifically on the pediatric population, such as the "Bench to Bassinet" initiative and the PumpKIN program developing ventricular assist devices for children. Others are more broadly based but relevant to pediatrics, such as the Programs of Excellence in Nanotechnology (PEN) program, and the NHLBI Progenitor Cell Biology Consortium. This talk will highlight programs relevant to the pediatric population, with examples of research being supported.

Denis B. Buxton, PhD, joined the National Heart, Lung, and Blood Institute (NHLBI) as a senior fellow in 1996. Dr. Buxton was appointed Assistant Director of the Heart Research Program in NHLBI's Division of Heart and Vascular Diseases in 2001 and a year later took on an additional role as a Health Science Administrator in the Institute's Bioengineering and Genomics Applications Group. In 2005, he was appointed Acting Director of the Heart Research Program. In 2006, he became Chief, Advanced Technologies & Surgery Branch in the Division of Cardiovascular Diseases. Currently Dr. Buxton is Associate Director of the Basic and Early Translational Research Program. His areas of expertise are molecular imaging, nanotechnology, myocardial ischemia and reperfusion, and stem cell transplantation.

Related Links

Additional Information

In Campus Calendar
No
Groups

Parker H. Petit Institute for Bioengineering and Bioscience (IBB)

Invited Audience
No audiences were selected.
Categories
Seminar/Lecture/Colloquium
Keywords
Denis Buxton, Nanomedicine and Stem Cell Research Programs at NHLBI
Status
  • Created By: Colly Mitchell
  • Workflow Status: Published
  • Created On: Aug 22, 2012 - 8:19am
  • Last Updated: Oct 7, 2016 - 9:59pm